Ecosystem

Part of Europe’s paediatric cancer research ecosystem

EPICA-DIPG is part of a coordinated European effort to advance clinical research in paediatric cancer under the EU Cancer Mission cluster “Diagnosis and Treatment – Innovative clinical trials for paediatric cancer”.

Together with PHOENIX and THEODORA, EPICA-DIPG contributes to a shared framework for developing and evaluating innovative clinical trial approaches.

Phoenix

Oral ER-stress inducer for aggressive paediatric solid tumours.
A first-in-child, multicentre Phase I/II trial of ibrilatazar in relapsed or refractory neuroblastoma and other aggressive solid tumours.

RESEARCH FOCUS
Safety, efficacy, combination treatment and translational biomarkers.

COORDINATOR
Vall d’Hebron Research Institute (VHIR)

COORDINATING COUNTRY
Spain

EPICA-DIPG

Immunotherapy trial for diffuse intrinsic pontine glioma.

A multinational early-phase clinical trial evaluating a complex immunotherapy approach for DIPG together with companion diagnostics and cross-centre delivery.

RESEARCH FOCUS
Safety, efficacy, combination treatment and translational biomarkers.

COORDINATOR
Sant Joan de Déu Research Institute

COORDINATING COUNTRY
Spain

Theodora

Neogene-targeting immunotherapies for paediatric sarcomas
A European master-protocol framework for early-stage trials, beginning with engineered TCR-T cells targeting an Ewing sarcoma-specific neogene.

RESEARCH FOCUS
TCR-T therapy, liquid biopsy, AI-enhanced imaging, immune profiling and patient-reported outcomes.

COORDINATOR
Institut Curie

COORDINATING COUNTRY
France

How the cluster works

The three projects collaborate through joint activities aligned with the objectives of the EU Cancer Mission.

01

Scientific exchange

Regular coordination and meetings

02

Joint events

Workshops and webinars

03

Shared dissemination

Publications and communication

04

Stakeholder engagement

Patients, families, researchers and policymakers

05

Cross-project learning

Supporting future research approaches

EuROPEAN ECOSYSTEM DATA

A shared European commitment to understanding cancer

UNCAN.eu (European Initiative to UNderstand CANcer) is one of the 13 specific objectives of the EU Mission on Cancer and one of the ten flagship initiatives of Europe’s Beating Cancer Plan.

Its development was prepared through 4.UNCAN.eu, a Coordination and Support Action established to produce a blueprint for the future UNCAN.eu research data platform. This included a strategy for a federated cancer research data hub and a set of cross-border research use cases.

EPICA-DIPG contributes to the development of the future UNCAN.eu platform by supporting the structured sharing and reuse of cancer research data.

Structuring data for future research

Clinical, biological and imaging data generated by the project will be structured and shared to support reuse in future research, particularly in rare paediatric cancers where data availability remains limited.

Where appropriate, data will also be made available through complementary European platforms, contributing to a broader ecosystem of interoperable cancer research data.

FAIR research data

F

Findable

Described and indexed so relevant datasets and outputs can be discovered.

A

Accessible

Available through clear, proportionate access conditions.

I

Interoperable

Structured to work with other European data resources and standards.

R

Reusable

Documented and prepared to support new analyses, tools and studies.

Ecosystem infraestructures

European infrastructures and networks

EPICA-DIPG is connected to research infrastructures and initiatives that support clinical research, data management and collaboration in paediatric oncology.

These infrastructures, networks and platforms support the collection, management and sharing of high-quality data across countries, while strengthening interoperable and collaborative research approaches.

  • Clinical and translational research
  • Data and samples
  • European collaboration
  • 1+ Million Genomes Initiative

    Genomic data sharing

    Supports secure cross-border access to genomic and linked clinical data for research and personalised healthcare.

  • BBMRI-ERIC

    Biobanking and samples

    Connects biobanks and biomolecular resources, supporting access to quality-controlled samples and associated data.

  • Conect4children

    Paediatric medicines development

    Provides a pan-European network and services to improve the design and delivery of paediatric clinical trials.

  • EATRIS

    Translational medicine

    Supports the translation of scientific discoveries into diagnostics, medicines and other health interventions through expertise, facilities and services.

  • ECRIN / PedCRIN

    Multinational clinical studies

    Facilitates multinational clinical research and connects paediatric trial expertise across countries.

  • EGA

    Controlled biomedical data

    Provides secure archiving and authorised access for sensitive genomic, phenotypic and clinical datasets.

  • ELIXIR

    Life-science data

    Provides coordinated bioinformatics resources, standards and services that help make life-science data usable across Europe.

  • ERDERA

    Rare disease collaboration

    Brings together research, data, clinical expertise and funding approaches to accelerate rare disease research.

  • ERN PaedCan

    Paediatric cancer expertise

    Connects specialist centres and expertise for children and adolescents with cancer across Europe.

  • ITCC4

    Early-phase paediatric oncology

    Supports collaborative early clinical research and the development of innovative treatments in paediatric oncology.

Stay informed

Subscribe to our Newsletter

Receive selected project updates, milestones, outputs and cluster news.